The FDA approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease.
Continue readingContact Us: 1-518-583-0095 
We’re Hiring… Join Our Team!
Industry News: Clinical Trial Finds that Virtual Reality Therapy May Serve as Effective Adjunct to Anesthesia For Surgical Procedures
The results of a clinical trial using software from XRHealth, developer and operator of virtual treatment rooms in the metaverse, demonstrated that virtual reality therapy may serve as an effective adjunct to anesthesia for surgical procedures. The trials were conducted with XRHealth’s immersive virtual reality software.
Continue readingIndustry News: FDA Finalizes Historic Rule Enabling Access to Over-the-Counter Hearing Aids for Millions of Americans
The FDA issued a final rule to improve access to hearing aids which may in turn lower costs for millions of Americans. This action establishes a new category of over-the-counter (OTC) hearing aids, enabling consumers with perceived mild to moderate hearing impairment to purchase hearing aids directly from stores or online retailers without the need for a medical exam, prescription or a fitting adjustment by an audiologist.
Continue readingIndustry News: Brain MRI surveillance needed for TKl-treated ALK or ROS7-positive NSCLC
Retrospective data showed how common central nervous system metastases are among patients with non-small cell lung cancer and ALK or ROS1 alterations who have been treated with tyrosine kinase inhibitors.
Continue readingIndustry News: Completion of Enrollment in Pivotal Phase 3 Trial of TAVT-45 for the Treatment of Metastatic Prostate Cancer
Novel Oral Suspension Formulation of Abiraterone Acetate Designed to Address Needs of Metastatic Prostate Cancer Patients Who Have Difficulty Swallowing (Dysphagia), an Issue for 20 to 30 Percent of Prostate Cancer Patients
Continue readingIndustry News: Two new studies substantiate prune’s role in bone health and digestive health
More than a simple snack, prunes have achieved superfood status due to their known benefits on bone, digestive, and cardiovascular health. Now, two new studies add further evidence to confirm the positive role that prunes have on overall health.
Continue readingIndustry News: FDA Clears DyAnsys Neurostimulation Device First Relief to treat Diabetic Neuropathic Pain
First Relief, a PENS (percutaneous electrical neurostimulation) device, has been cleared by the FDA for multiple treatments up to 56 days for symptomatic relief of chronic, intractable pain from diabetic peripheral neuropathy. It is applied behind the ear and delivers continuous pulses of a low-level electrical current over several days.
Continue readingIndustry News: Insightec receives FDA IDE approval for prostate cancer comparative study using high intensity focused ultrasound
Insightec announced that it has received FDA approval for an investigational device exemption (IDE) for a clinical comparative study of the Exablate Prostate system used to treat diseased prostate tissue. This study will evaluate the safety and efficacy of focal treatment using high intensity focused ultrasound when compared to active surveillance in men living with prostate cancer.
Continue readingIndustry News: Patients Took Drug Dostarlimab For Six Months, Results Showed Their Tumors Disappeared
Recently a small cancer study showed the unprecedented result of 100 percent of participants in remission. A study at Memorial Sloan Kettering Cancer Center in New York showed encouraging results using immunotherapy treatment with the drug Dostralimab.
Continue readingIndustry News: Smallest Ever Custom mmWave Sensor Designed for Non-Invasive Glucose and Cuffless Blood Pressure Monitoring
Movano Inc. was granted a new U.S. patent for the sensor’s architecture that will enable accurate and cost-effective health monitoring in future medical devices
Continue reading